title: Review: Stent fracture in the drug-eluting stent era.
abstract: Stent fracture has been recognized as one cause of stent failure and has been associated with in-stent restenosis and stent thrombosis, even in 2nd-generation drug-eluting stents. Given the wide use of drug-eluting stents and paucity of contemporary data available concerning stent fracture, we reviewed clinical studies and the Food and Drug Administration's Manufacturer and User Device Experience (MAUDE) database to analyze the current trends, mechanisms, predictors, outcomes and treatment for stent fracture.
authors: Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States.
authors: Alfazir
authors: A
authors: Omar
authors: Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States.
authors: Lakshmana K
authors: LK
authors: Pendyala
authors: Mercy Angiography, Mercy Hospital, Auckland, New Zealand.
authors: John A
authors: JA
authors: Ormiston
authors: Interventional Cardiology, MedStar Washington Hospital Center, Washington, DC, United States. Electronic address: ron.waksman@medstar.net.
authors: Ron
authors: R
authors: Waksman
mesh_terms: D002317:Cardiovascular Agents / Q000008:administration & dosage*; D023903:Coronary Restenosis / Q000209:etiology; D003328:Coronary Thrombosis / Q000209:etiology; D054855:Drug-Eluting Stents; D006801:Humans; D062645:Percutaneous Coronary Intervention / Q000009:adverse effects* / Q000295:instrumentation*; D011474:Prosthesis Design; D011475:Prosthesis Failure; D012307:Risk Factors; D016896:Treatment Outcome
chemical_list: D002317:Cardiovascular Agents
keywords: Drug-eluting stent; Fracture; Stent